;

Articles Not Curated - Drug Studies-in vitro
Last updated: 2021 Sep 7
Total hit(s): 91
S.No.
1
34400835
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution
Nat Microbiol
2021 Sep
27.9
1
2
34348021
Pharmacophore Model for SARS-CoV-2 3CLpro Small-Molecule Inhibitors and in Vitro Experimental Validation of Computationally Screened Inhibitors
J Chem Inf Model
2021 Aug 23
4.04
1
3
34452529
Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus
Viruses
2021 Aug 23
3.76
1
4
34423318
Fluorogenic in vitro activity assay for the main protease M(pro) from SARS-CoV-2 and its adaptation to the identification of inhibitors
STAR Protoc
2021 Aug 17
1
5
34404832
Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal
Sci Rep
2021 Aug 17
4.12
1
6
34442810
The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses
Microorganisms
2021 Aug 14
<3years
1
7
34192965
Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors
SLAS Discov
2021 Jul 1
1
8
34097489
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 In Vitro
Antimicrob Agents Chemother
2021 Jun 7
4.68
1
9
34090962
The folate antagonist methotrexate diminishes replication of the coronavirus SARS-CoV-2 and enhances the antiviral efficacy of remdesivir in cell culture models
Virus Res
2021 Jun 6
2.6
3
10
34209659
Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CL(Pro)) Activity
Foods
2021 Jun 29
1
11
34139040
Melatonin and other indoles show antiviral activities against swine coronaviruses in vitro at pharmacological concentrations
J Pineal Res
2021 Jun 17
1
12
34112764
Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction
Signal Transduct Target Ther
2021 Jun 10
<3years
1
13
34072087
Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries
Molecules
2021 May 27
3.01
1
14
34073231
3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery
Biomedicines
2021 May 26
3.6
1
15
34006835
Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction
Signal Transduct Target Ther
2021 May 18
<3years
2
16
34068686
The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL(pro) In Vitro
Viruses
2021 May 10
3.76
1
17
33713730
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors
Antiviral Res
2021 May
4.12
2
18
33825201
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro
Br J Pharmacol
2021 Apr 6
6.48
2
19
33917313
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
Pharmaceuticals (Basel)
2021 Apr 6
4.5
1
20
33903110
Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication
Antimicrob Agents Chemother
2021 Apr 26
4.68
1
21
33907750
Multidose evaluation of 6,710 drug repurposing library identifies potent SARS-CoV-2 infection inhibitors In Vitro and In Vivo
bioRxiv
2021 Apr 22
Its not a journal
1
22
33880524
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
J Antimicrob Chemother
2021 Apr 21
4.94
3
23
33821265
Discovery and in-vitro evaluation of potent SARS-CoV-2 entry inhibitors
bioRxiv
2021 Apr 2
Its not a journal
1
24
33919584
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro
Biomedicines
2021 Apr 18
3.6
1
25
33686143
The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
Sci Rep
2021 Mar 8
4.12
4